Last reviewed · How we verify
NCT06859879: RESTORE-ENG
A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults
NA trial testing Dietary Supplement: low-dose Rosemary and Daylily extract in Sleep in 10 participants. Completed in 15 December 2025.
30 November 2025
Quick facts
| Lead sponsor | University of Novi Sad, Faculty of Sport and Physical Education |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 April 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 15 December 2025 |
| Sites | 1 location across Serbia |
Drugs / interventions tested
- Dietary Supplement: low-dose Rosemary and Daylily extract
- Dietary Supplement: medium-dose Rosemary and Daylily extract
- Dietary Supplement: control
Conditions studied
- Sleep — all drugs for Sleep →
Sponsor
University of Novi Sad, Faculty of Sport and Physical Education
Who can join
50 and older, any sex, with Sleep. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the impact of supplementation with two different doses of Rosemary and Daylily herbal extract on various health outcomes in middle-aged adults. Over an eight-week period, the trial will assess improvements in sleep quality, circadian rhythms, energy metabolism, and relevant biochemical markers. The study employs a randomized, placebo-controlled, crossover design to evaluate the efficacy of these supplements in enhancing overall health and well-being.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06859879
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep
Currently open trials in the same condition.
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
- NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting
- NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
Other University of Novi Sad, Faculty of Sport and Physical Education trials
Trials by the same sponsor.
- NCT06968715 — Hydrogen-Rich Water and Metabolic Health in Adults: A 12-Week Randomized Trial · NA · completed
- NCT06788015 — Hydrogen-Infused Water for Endurance Performance, Body Hydration Biomarkers, and Health-Related Quality of Life · NA · completed
- NCT06660004 — Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women · NA · completed
- NCT06722326 — Hydrogen-rich Water and Appetite in Obesity · NA · completed
- NCT06371651 — Creatine and GAA for Brain Oxygenation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06859879 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Novi Sad, Faculty of Sport and Physical Education
- Last refreshed: 2 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06859879.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing